BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24252154)

  • 1. Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator.
    Wan C; Herzog CA; Zareba W; Szymkiewicz SJ
    Ann Noninvasive Electrocardiol; 2014 May; 19(3):247-57. PubMed ID: 24252154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Patients With In-Hospital Ventricular Tachycardia and Ventricular Fibrillation Arrest While Using a Wearable Cardioverter Defibrillator.
    Ellenbogen KA; Wan C; Shavelle DM
    Am J Cardiol; 2018 Jan; 121(2):205-209. PubMed ID: 29153771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
    Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.
    Chung MK; Szymkiewicz SJ; Shao M; Zishiri E; Niebauer MJ; Lindsay BD; Tchou PJ
    J Am Coll Cardiol; 2010 Jul; 56(3):194-203. PubMed ID: 20620738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Initial Recorded Rhythm on Cardioverter-Defibrillator Insertion and Subsequent All-Cause Mortality in Sudden Cardiac Arrest Survivors.
    Polsinelli VB; Wang NC; Kancharla K; Bhonsale A; Jain SK; Saba S
    Am J Cardiol; 2019 Sep; 124(5):709-714. PubMed ID: 31279406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM; Hillmann HAK; Proctor T; Kieser M; Scholz E; Zitron E; Katus HA; Thomas D
    Heart Vessels; 2018 Nov; 33(11):1390-1402. PubMed ID: 29721674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA; Carrillo RG
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Risk Factors of Sudden Cardiac Death in End-Stage Renal Disease Patients Undergoing Hemodialysis: A Retrospective Study.
    Khan MT; Hameed B; Ahmed J
    Saudi J Kidney Dis Transpl; 2021; 32(4):957-966. PubMed ID: 35229792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW; Vamos M; Sirat AS; Hohnloser SH
    Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Shock Asystole in Patients Dying Out of Hospital While Wearing a Cardioverter Defibrillator.
    Berger JM; Sengupta JD; Bank AJ; Casey SA; Sharkey SW; Stanberry LI; Hauser RG
    JACC Clin Electrophysiol; 2023 Aug; 9(8 Pt 1):1333-1339. PubMed ID: 37558289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and predictors of implantable cardioverter defibrillator implantation after sudden cardiac arrest: Insight from the national inpatient sample.
    Munir MB; Alqahtani F; Aljohani S; Bhirud A; Modi S; Alkhouli M
    Pacing Clin Electrophysiol; 2018 Mar; 41(3):229-237. PubMed ID: 29318626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
    Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy.
    Lamichhane M; Gardiner JC; Bianco NR; Szymkiewicz SJ; Thakur RK
    J Interv Card Electrophysiol; 2017 Jan; 48(1):11-19. PubMed ID: 27752809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.